• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

插入缺失在人类癌症基因体细胞突变中的重要作用。

Important role of indels in somatic mutations of human cancer genes.

机构信息

State Key Laboratory of Pharmaceutical Biotechnology, Department of Biology, Nanjing University, Nanjing 210093, China.

出版信息

BMC Med Genet. 2010 Sep 1;11:128. doi: 10.1186/1471-2350-11-128.

DOI:10.1186/1471-2350-11-128
PMID:20807447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2940769/
Abstract

BACKGROUND

Cancer is clonal proliferation that arises owing to mutations in a subset of genes that confer growth advantage. More and more cancer related genes are found to have accumulated somatic mutations. However, little has been reported about mutational patterns of insertions/deletions (indels) in these genes.

RESULTS

We analyzed indels' abundance and distribution, the relative ratio between indels and somatic base substitutions and the association between those two forms of mutations in a large number of somatic mutations in the Catalogue of Somatic Mutations in Cancer database. We found a strong correlation between indels and base substitutions in cancer-related genes and showed that they tend to concentrate at the same locus in the coding sequences within the same samples. More importantly, a much higher proportion of indels were observed in somatic mutations, as compared to meiotic ones. Furthermore, our analysis demonstrated a great diversity of indels at some loci of cancer-related genes. Particularly in the genes with abundant mutations, the proportion of 3n indels in oncogenes is 7.9 times higher than that in tumor suppressor genes.

CONCLUSIONS

There are three distinct patterns of indel distribution in somatic mutations: high proportion, great abundance and non-random distribution. Because of the great influence of indels on gene function (e.g., the effect of frameshift mutation), these patterns indicate that indels are frequently under positive selection and can often be the 'driver mutations' in oncogenesis. Such driver forces can better explain why much less frameshift mutations are in oncogenes while much more in tumor suppressor genes, because of their different function in oncogenesis. These findings contribute to our understanding of mutational patterns and the relationship between indels and cancer.

摘要

背景

癌症是克隆性增殖,它源于在赋予生长优势的一组基因中的亚群发生突变。越来越多的癌症相关基因被发现积累了体细胞突变。然而,关于这些基因中插入/缺失(indels)的突变模式却鲜有报道。

结果

我们在大量癌症体细胞突变的 Catalogue of Somatic Mutations in Cancer 数据库中分析了 indels 的丰度和分布、indels 与体细胞碱基替换之间的相对比值,以及这两种突变形式之间的关联。我们发现癌症相关基因中的 indels 与碱基替换之间存在很强的相关性,并表明它们倾向于在同一样本的编码序列中同一基因座集中出现。更重要的是,体细胞突变中的 indels 比例比减数分裂中的要高得多。此外,我们的分析还表明,在一些癌症相关基因的某些基因座上存在着高度多样化的 indels。特别是在突变丰富的基因中,致癌基因中 3n indels 的比例比肿瘤抑制基因高 7.9 倍。

结论

体细胞突变中存在三种不同的 indel 分布模式:高比例、大量和非随机分布。由于 indels 对基因功能的巨大影响(例如,移码突变的影响),这些模式表明 indels 经常受到正向选择,并且通常可以作为致癌作用中的“驱动突变”。这些驱动因素可以更好地解释为什么在致癌基因中很少有移码突变,而在肿瘤抑制基因中却有很多,因为它们在致癌作用中的功能不同。这些发现有助于我们理解突变模式以及 indels 与癌症之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec8/2940769/54548d7197bf/1471-2350-11-128-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec8/2940769/3d57bc86311c/1471-2350-11-128-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec8/2940769/ccb463271ff8/1471-2350-11-128-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec8/2940769/539c22356e47/1471-2350-11-128-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec8/2940769/90f75dd848cd/1471-2350-11-128-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec8/2940769/54548d7197bf/1471-2350-11-128-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec8/2940769/3d57bc86311c/1471-2350-11-128-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec8/2940769/ccb463271ff8/1471-2350-11-128-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec8/2940769/539c22356e47/1471-2350-11-128-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec8/2940769/90f75dd848cd/1471-2350-11-128-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ec8/2940769/54548d7197bf/1471-2350-11-128-5.jpg

相似文献

1
Important role of indels in somatic mutations of human cancer genes.插入缺失在人类癌症基因体细胞突变中的重要作用。
BMC Med Genet. 2010 Sep 1;11:128. doi: 10.1186/1471-2350-11-128.
2
Identifying the Impact of Inframe Insertions and Deletions on Protein Function in Cancer.确定框内插入和缺失对癌症中蛋白质功能的影响。
J Comput Biol. 2020 May;27(5):786-795. doi: 10.1089/cmb.2018.0192. Epub 2019 Aug 28.
3
An analysis of substitution, deletion and insertion mutations in cancer genes.癌症基因中的替换、缺失和插入突变分析。
Nucleic Acids Res. 2012 Aug;40(14):6401-13. doi: 10.1093/nar/gks290. Epub 2012 Apr 9.
4
PredCID: prediction of driver frameshift indels in human cancer.PredCID:人类癌症中驱动移码插入缺失的预测
Brief Bioinform. 2021 May 20;22(3). doi: 10.1093/bib/bbaa119.
5
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis.插入缺失衍生的肿瘤特异性新抗原和免疫表型:泛癌分析。
Lancet Oncol. 2017 Aug;18(8):1009-1021. doi: 10.1016/S1470-2045(17)30516-8. Epub 2017 Jul 7.
6
Remarkable difference of somatic mutation patterns between oncogenes and tumor suppressor genes.癌基因和抑癌基因的体细胞突变模式存在显著差异。
Oncol Rep. 2011 Dec;26(6):1539-46. doi: 10.3892/or.2011.1443. Epub 2011 Sep 1.
7
dbCID: a manually curated resource for exploring the driver indels in human cancer.dbCID:一个用于探索人类癌症中驱动因子插入缺失的人工 curated 资源。
Brief Bioinform. 2019 Sep 27;20(5):1925-1933. doi: 10.1093/bib/bby059.
8
Analysis of somatic microsatellite indels identifies driver events in human tumors.体细胞微卫星插入缺失分析可识别人类肿瘤中的驱动事件。
Nat Biotechnol. 2017 Oct;35(10):951-959. doi: 10.1038/nbt.3966. Epub 2017 Sep 11.
9
Structural and functional analysis of somatic coding and UTR indels in breast and lung cancer genomes.体细胞编码和 UTR 插入缺失在乳腺癌和肺癌基因组中的结构和功能分析。
Sci Rep. 2021 Oct 27;11(1):21178. doi: 10.1038/s41598-021-00583-1.
10
Systematic discovery of complex insertions and deletions in human cancers.人类癌症中复杂插入和缺失的系统性发现。
Nat Med. 2016 Jan;22(1):97-104. doi: 10.1038/nm.4002. Epub 2015 Dec 14.

引用本文的文献

1
Insertions and Deletions: Computational Methods, Evolutionary Dynamics, and Biological Applications.插入和缺失:计算方法、进化动态和生物应用。
Mol Biol Evol. 2024 Sep 4;41(9). doi: 10.1093/molbev/msae177.
2
Copy number losses of oncogenes and gains of tumor suppressor genes generate common driver mutations.癌基因的拷贝数缺失和肿瘤抑制基因的获得会产生常见的驱动突变。
Nat Commun. 2024 Jul 20;15(1):6139. doi: 10.1038/s41467-024-50552-1.
3
Extend the benchmarking indel set by manual review using the individual cell line sequencing data from the Sequencing Quality Control 2 (SEQC2) project.

本文引用的文献

1
Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis.有丝分裂同源重组维持基因组稳定性并抑制肿瘤发生。
Nat Rev Mol Cell Biol. 2010 Mar;11(3):196-207. doi: 10.1038/nrm2851.
2
A comprehensive catalogue of somatic mutations from a human cancer genome.一个人类癌症基因组中体细胞突变的综合目录。
Nature. 2010 Jan 14;463(7278):191-6. doi: 10.1038/nature08658. Epub 2009 Dec 16.
3
COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer.
使用来自测序质量控制 2(SEQC2)项目的个体细胞系测序数据,通过手动审查扩展基准插入缺失集。
Sci Rep. 2024 Mar 25;14(1):7028. doi: 10.1038/s41598-024-57439-7.
4
Immunogenicity in renal cell carcinoma: shifting focus to alternative sources of tumour-specific antigens.肾细胞癌的免疫原性:将焦点转移到肿瘤特异性抗原的替代来源上。
Nat Rev Nephrol. 2023 Jul;19(7):440-450. doi: 10.1038/s41581-023-00700-5. Epub 2023 Mar 27.
5
Pre-Existing and Acquired Resistance to PARP Inhibitor-Induced Synthetic Lethality.对PARP抑制剂诱导的合成致死的固有和获得性抗性
Cancers (Basel). 2022 Nov 24;14(23):5795. doi: 10.3390/cancers14235795.
6
Evolutionary Dynamics of Indels in SARS-CoV-2 Spike Glycoprotein.严重急性呼吸综合征冠状病毒2刺突糖蛋白中插入缺失的进化动力学
Evol Bioinform Online. 2021 Dec 6;17:11769343211064616. doi: 10.1177/11769343211064616. eCollection 2021.
7
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma.高剂量白细胞介素-2 和立体定向消融放疗治疗转移性肾细胞癌的 II 期试验的结果和免疫相关性。
Clin Cancer Res. 2021 Dec 15;27(24):6716-6725. doi: 10.1158/1078-0432.CCR-21-2083. Epub 2021 Sep 22.
8
Identifying modules of cooperating cancer drivers.鉴定协同致癌驱动子的模块。
Mol Syst Biol. 2021 Mar;17(3):e9810. doi: 10.15252/msb.20209810.
9
Production of an aberrant splice variant of CCL5 is not caused by genetic mutation in the mammary glands of mastitis‑infected Holstein cows.在乳腺炎感染的荷斯坦奶牛的乳腺中,CCL5 的异常剪接变异体的产生不是由基因突变引起的。
Mol Med Rep. 2019 May;19(5):4159-4166. doi: 10.3892/mmr.2019.10103. Epub 2019 Mar 28.
10
BatAlign: an incremental method for accurate alignment of sequencing reads.BatAlign:一种用于测序读段精确比对的增量方法。
Nucleic Acids Res. 2015 Sep 18;43(16):e107. doi: 10.1093/nar/gkv533. Epub 2015 Jul 13.
COSMIC(癌症体细胞突变目录):一个用于研究人类癌症中获得性突变的资源。
Nucleic Acids Res. 2010 Jan;38(Database issue):D652-7. doi: 10.1093/nar/gkp995. Epub 2009 Nov 11.
4
Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.由SNF5肿瘤抑制因子缺失引起的肿瘤发生依赖于BRG1的活性,BRG1是SWI/SNF染色质重塑复合物的ATP酶。
Cancer Res. 2009 Oct 15;69(20):8094-101. doi: 10.1158/0008-5472.CAN-09-0733. Epub 2009 Sep 29.
5
Genomic mutation rates: what high-throughput methods can tell us.基因组突变率:高通量方法能告诉我们什么。
Bioessays. 2009 Sep;31(9):912-20. doi: 10.1002/bies.200900017.
6
A highly annotated whole-genome sequence of a Korean individual.一名韩国个体的高度注释全基因组序列。
Nature. 2009 Aug 20;460(7258):1011-5. doi: 10.1038/nature08211. Epub 2009 Jul 8.
7
Genomewide association between insertions/deletions and the nucleotide diversity in bacteria.细菌中插入/缺失与核苷酸多样性之间的全基因组关联
Mol Biol Evol. 2009 Oct;26(10):2353-61. doi: 10.1093/molbev/msp144. Epub 2009 Jul 8.
8
The cancer genome.癌症基因组
Nature. 2009 Apr 9;458(7239):719-24. doi: 10.1038/nature07943.
9
Variation in the ratio of nucleotide substitution and indel rates across genomes in mammals and bacteria.哺乳动物和细菌基因组中核苷酸替换率与插入缺失率之比的变化。
Mol Biol Evol. 2009 Jul;26(7):1523-31. doi: 10.1093/molbev/msp063. Epub 2009 Mar 27.
10
Cancer: Inflaming metastasis.癌症:炎症促进转移。
Nature. 2009 Jan 1;457(7225):36-7. doi: 10.1038/457036b.